BG
NXGN

Bahl & Gaynor’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bahl & Gaynor’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,153
Closed -$256K – 400
2013
Q4 		$256K Buy
12,153
+865
+8% +$19.5K ﹤0.01% 347
2013
Q3 		$245K Hold
11,288
– – ﹤0.01% 336
2013
Q2 		$211K Buy
+11,288
New +$206K ﹤0.01% 345

Other funds holding NXGN

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bahl & Gaynor's NXGN Position: Q1 2014 in Review

Bahl & Gaynor sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2014, closing a stake of 12,153 shares — an estimated $256K sold.

Bahl & Gaynor first reported a position in NXGN in Q2 2013 and held it in 3 quarters. The position peaked at $256K in Q4 2013. 163 funds tracked by Wall St. Rank hold NXGN as of Q1 2014.

  • Bahl & Gaynor reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Bahl & Gaynor sold 12,153 NextGen Healthcare, Inc. Common Stock shares in Q1 2014, an estimated $256K.
  • Bahl & Gaynor first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Bahl & Gaynor's NextGen Healthcare, Inc. Common Stock position peaked at $256K in Q4 2013.
  • 163 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2014.

Based on Bahl & Gaynor's 13F filing for Q1 2014, filed 20 May 2014.